Synergy Pharma (SGYP) Shares Slump Early; Allergan Interest Questioned

August 24, 2016 9:39 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated - August 24, 2016 9:51 AM EDT)

Synergy Pharma (Nasdaq: SGYP) shares are down early Wednesday. The stock is off around 5 percent with heavy volume at the start. Today's trading action follows a 3 percent drop on Tuesday.

UPDATE - on Mad Money Monday night, Jim Cramer commented:

I don't think that Brent Saunders [CEO of Allergan] is going to buy them ... Look, it's had a good run. It's almost doubled. I would say it's for speculation only. Remember, it can pull back. It's had such a big run.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog, Mergers and Acquisitions, Rumors, Trader Talk

Related Entities

Jim Cramer

Add Your Comment